Search

Your search keyword '"Fennell, Kimberly F."' showing total 21 results

Search Constraints

Start Over You searched for: Author "Fennell, Kimberly F." Remove constraint Author: "Fennell, Kimberly F."
21 results on '"Fennell, Kimberly F."'

Search Results

1. An inverse agonist of orphan receptor GPR61 acts by a G protein-competitive allosteric mechanism

2. Structural basis of the acyl-transfer mechanism of human GPAT1

4. An inverse agonist of orphan receptor GPR61 reveals a novel allosteric mechanism

5. Discovery of High-Affinity Small-Molecule Binders of the Epigenetic Reader YEATS4

6. Structural basis of the acyl-transfer mechanism of human GPAT1

8. Discovery of High-Affinity Small-Molecule Binders of the Epigenetic Reader YEATS4.

10. Machine Learning for Prioritization of Thermostabilizing Mutations for G-Protein Coupled Receptors

11. Discovery of 3-Cyano-N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)benzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse Agonist

12. Correction to Application of Structure-Based Design and Parallel Chemistry to Identify a Potent, Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor

13. Application of Structure-Based Design and Parallel Chemistry to Identify a Potent, Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor

14. Discovery and structural characterization of an allosteric inhibitor of bacterial cis-prenyltransferase

15. Discovery of a Selective Covalent Inhibitor of Lysophospholipase-like 1 (LYPLAL1) as a Tool to Evaluate the Role of this Serine Hydrolase in Metabolism

16. What The Structure Of Human Liver Glycogen Phosphorylase A Tells Us About Its Regulation

18. Use of Structure-Based Design to Discover a Potent, Selective, In Vivo Active Phosphodiesterase 10A Inhibitor Lead Series for the Treatment of Schizophrenia

19. Discovery and structural characterization of an allosteric inhibitor of bacterial c is-prenyltransferase.

21. Discovery of 3-Cyano- N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1 H-pyrrolo[2,3- b]pyridin-5-yl)benzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse Agonist.

Catalog

Books, media, physical & digital resources